Lisofylline decreases white cell adhesiveness and improves survival after experimental hemorrhagic shock

Critical Care Medicine

Volumn 24, Issue 10, 1996, Pages 1724-1728

  Waxman, Kenneth ^a   Daughters, Kenneth ^a   Aswani, Sharda ^a   Rice, Glenn ^a  

^a NONE

Author keywords

activation; adhesiveness; critical illness; hemorrhage; leukocy te; lisofylline; microcirculation; shock; white blood cell

Indexed keywords

LISOFYLLINE; METHYLXANTHINE DERIVATIVE; PLACEBO; RINGER LACTATE SOLUTION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; CRITICAL ILLNESS; DOWN REGULATION; DRUG EFFICACY; FLUID THERAPY; HEMORRHAGIC SHOCK; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; LEUKOCYTE COUNT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RESUSCITATION; SURVIVAL RATE; THROMBOCYTE ADHESIVENESS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BLOOD PRESSURE; CELL ADHESION; LEUKOCYTES; MALE; PENTOXIFYLLINE; PLATELET ADHESIVENESS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RESUSCITATION; SHOCK, HEMORRHAGIC;

EID: 0029908319     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199610000-00021     Document Type: Article

References (19)

1. Vedder NB, Fouty BW, Winn RK, et al: Role of neutrophils in generalized reperfusion injury associated with resuscitation from shock. Surgery 1989; 106:509-516
2. Barroso-Aranda J, Schmid-Schonbein GW, Zweifach BW, et al: Granulocytes and no-reflow phenomenon in irreversible hemorrhagic shock. Circ Res 1988; 63:437-447
3. Waxman K, Clark L, Soliman MH, et al: Pentoxifylline in resuscitation of experimental hemorrhagic shock. Crit Care Med 1991; 19:728-731
4. Zapata-Sirvent RL, Hansbrough JF, Cox MC, et al: Immunologic alterations in a murine model of hemorrhagic shock. Crit Care Med 1992; 20:508-517
5. Barroso-Aranda J, Chavez-Chavez RH, Schmid-Schonbein GW: Spontaneous neutrophil activation and the outcome of hemorrhagic shock in rabbits. Circ Shock 1992; 36:85-90
6. Mileski WJ, Winn RK, Vedder NB, et al: Inhibition of CD18-dependent neutrophil adherence reduces organ injury after hemorrhagic shock in primates. Surgery 1990; 108:206-212
7. Vedder NB, Winn RK, Rice CL, et al: A monoclonal antibody to the adherence promoting leukocyte glycoprotein CD-18 reduces organ injury and improves survival from hemorrhagic shock and resuscitation. J Clin Invest 1988; 81:939-944
8. Rice GC, Brown PA, Nelson RJ, et al: Protection from endotoxic shock in mice by pharmacologic inhibition of phosphatidic acid. Proc Natl Acad Sci USA 1994; 91:3857-3861
9. Abraham E, Bursten S, Shenkar R, et al: Phosphatidic acid signaling mediates lung cytokine expression and lung inflammation injury after hemorrhage in mice. J Exp Med 1995; 181:569-575
10. Hasegawa N, Oka Y, Nakayama F, et al: The effect of inhibition of phosphatidic acid generation by lisofylline on sepsis-induced acute lung injury in minipigs. Abstr. Am J Respir Crit Care Med 1995; 151:A764
11. Aziz S, Suzuki K, Rice G, et al: Prolongation of discordant cardiac xenotransplantation survival by lisofylline, a phosphatidic acid inhibitor. Transplant Proc 1996; 28:740
12. Guidot DM, Rice GC, Singer JW, et al: Inhibition of lyso-phosphatidic acid acyl transferase (LPAAT) activity by CT-1501R suppresses neutrophil adherence and chemotaxis in-vitro and decreases interleukin-8 induced injury in isolated rat lungs perfused with human neutrophils. Abstr. Clin Res 1994; 42:145A
13. Rice GC, Rosen J, Weeks R, et al: CT-1501R selectively inhibits induced inflammatory monokines in human whole blood ex vivo. Shock 1994; 1: 254-266
14. Thompson JA, Nemunaitis J, Jain V, et al: Preliminary results of a phase I trial of CT-1501R in cancer patients receiving high dose interleukin-2 (IL-2). Abstr. Blood 1993; 81:363A
15. Bursten SL, Weeks R, West J, et al: Potential role for phosphatidic acid in mediating the inflammatory responses to TNFa and IL-1β. Circ Shock 1994; 44:14-29
16. Bursten SL, Harris WE, Bomsztyk K, et al: Interleukin-1 rapidly stimulates lysophosphatidate acyltransferase and phosphatidate phosphohydrolase activities in human mesangial cells. J Biol Chem 1991; 266:20732-20743
17. Rothe J, Lesslauer W, Lotscher H, et al: Mice lacking the tumor necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 1993; 364:798-802
18. Rouse MS, Brandt CM, Laue WR, et al: Effect of lisofylline on ampicillin treatment of pneumococcal experimental pneumonia. Abstr 1557. Interscience Conference on Antimicrobial Agents in Chemotherapy (ICAAC) Meeting, San Francisco, CA, 1995. Session 99, A85, In Press
19. Bauldry SA, Bass DA, Cousart SL, et al: Tumor necrosis factor alpha priming of phospholipase D in human neutrophils. Correlation between phosphatidic acid production and superoxide generation. J Biol Chem 1991; 266:4173-4179